Preferred Conformations of Captopril and Its Disulfide Metabolite in Deuterium Oxide Deduced from 200 MHz1H NMR Spectra
- 1 July 1985
- journal article
- Published by Taylor & Francis in Spectroscopy Letters
- Vol. 18 (6) , 419-424
- https://doi.org/10.1080/00387018508062241
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Captopril and Its Disulfide Metabolite:13C NMR Assignments and Preferred ConformationsSpectroscopy Letters, 1983
- The relationship between proton-proton NMR coupling constants and substituent electronegativities—ITetrahedron, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Angiotensin Converting-Enzyme Inhibitor in Refractory HypertensionNew England Journal of Medicine, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acidsBiochemistry, 1977
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977